A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Hereditary haemochromatosis (HH), which affects some 1 in 400 and has an estimated carrier frequency of 1 in 10 individuals of Northern European descent, results in multi-organ dysfunction caused by increased iron deposition, and is treatable if detected early. Using linkage-disequilibrium and full haplotype analysis, we have identified a 250-kilobase region more than 3 megabases telomeric of the major histocompatibility complex (MHC) that is identical-by-descent in 85% of patient chromosomes. Within this region, we have identified a gene related to the MHC class I family, termed HLA-H, containing two missense alterations. One of these is predicted to inactivate this class of proteins and was found homozygous in 83% of 178 patients. A role of this gene in haemochromatosis is supported by the frequency and nature of the major mutation and prior studies implicating MHC class I-like proteins in iron metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HFE encodes an atypical MHC class I molecule which plays a major role in the regulation of iron homeostasis under basal conditions (Feder et al., 1996; Ludwiczek et al., 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Feder et al., 1996
In the citing paper
“Two decades later that insight led to the identification of HFE (originally called HLA-H), the gene mutated in the large majority of patients with hemochromatosis.121”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [121]
In the citing paper
“This mutation disrupts the formation of the disulfide bridge, which appears to be necessary for proper protein formation, causing the aberrant protein remains in the Golgi (24, 83).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
In the citing paper
“Normal HFE protein associates with TfR, usually in conjunction with β2-microglobulin, and competes with Tf for TfR binding, thereby inhibiting Fe-Tf uptake via the TfR in cells (83, 179).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928
Shizuya, H., Birren, B., Kim, U. J., Mancino, V, Slepak, T., Tachiiri, Y., & Simon, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8794 · Cited by 1,671
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Current Protocols in Human Genetics
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142905 · Cited by 987
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 881
A new bacteriophage P1–derived vector for the propagation of large human DNA fragments
loannou, P. A., Amemiya, C. T., Garnes, J., Kroisel, P. M., Shizuya, H., Chen, C., Batzer, M. A., & de Jong, P. J. (1994) · Nature Genetics · doi:10.1038/ng0194-84 · Cited by 844
Research works printed but not linked: 1
- Hudson, T. et al. An STS-based map of the human genome. Science 270, 1945–1954, with supplementary data from the Whitehead Institute/MIT Center for Genome Research, human genetic mapping project, data release 10(May 1996) (1995). · DOI · Paper page
Cited by
Items 901–1,000 of 1,020
Revisiting Hereditary Hemochromatosis: Current Concepts and Progress
Yen, A. W., Fancher, T. L., & Bowlus, C. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.041 · Cited by 66
Iron Treatment Downregulates DMT1 and IREG1 mRNA Expression in Caco-2 Cells
Martini, L. A., Tchack, L., & Wood, R. J. (2002) · Journal of Nutrition · doi:10.1093/jn/132.4.693 · Cited by 62
Brittenham, G., Weiss, G., Brissot, P., Lainé, F., Guillygomarc’h, A., Guyader, D., Moirand, R., & Deugnier, Y. (2000) · Hematology · doi:10.1182/asheducation-2000.1.39 · Cited by 67
Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI
Berlin, D., Chong, G., Chertkow, H. M., Bergman, H., Phillips, N. A., & Schipper, H. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.06.008 · Cited by 60
Frequencies in the Japanese Population of HFE Gene Mutations
Sohda, T., 柳井淳一, Soejima, H., & Tamura, K. (1999) · Biochemical Genetics · doi:10.1023/a:1018718101579 · Cited by 59
“Recently, Feder et al. (1996) reported two separate mutations of the hemochromatosis gene (HFE), which might increase the susceptibility for HH.”
BackgroundLudwiczek, S., Theurl, I., Artner-Dworzak, E., Chorney, M., & Weiss, G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0542-3 · Cited by 57
“The affinity of transferrin-bound iron to TfR is affected by a non-classical MHC I molecule, HFE [ 4 , 5]. HFE interacts with TfR in such a way that binding of HFE to the TfR lowers its affinity for irontransferrin, resulting in the reduction of cellular iron uptake [6, 7].”
BackgroundBardou-Jacquet, E., Philip, J., Lorho, R., Ropert, M., Latournerie, M., Houssel-Debry, P., Guyader, D., Loréal, O., Boudjema, K., & Brissot, P. (2014) · Hepatology · doi:10.1002/hep.26570 · Cited by 58
The struggle for iron: gastrointestinal microbes modulate the host immune response during infection
Markel, T. A., Crisostomo, P. R., Wang, M., Herring, C. M., Meldrum, K. K., Lillemoe, K. D., & Meldrum, D. R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906579 · Cited by 56
“The HFE gene has been shown to be defective in those with hemochromatosis [94], suggesting that HFE limits the amount of iron absorption.”
BackgroundDiagnosis and treatment of hereditary hemochromatosis: an update
Kanwar, P., & Kowdley, K. V. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.816114 · Cited by 60
McLaren, G. D., & Gordeuk, V. R. (2009) · Hematology · doi:10.1182/asheducation-2009.1.195 · Cited by 66
“The most common form among Caucasian populations of northern European origin is related to mutations in the hemochromatosis (HFE) gene,(4-6) and 80% to 90% of Caucasian patients diagnosed with hemochromatosis in the United States are homozygous for the HFE C282Y mutation (nt845G→A; cys282tyr).(7,8) Another common muta…”
BackgroundFerristatin II Promotes Degradation of Transferrin Receptor-1 In Vitro and In Vivo
Byrne, S. L., Buckett, P. D., Kim, J., Luo, F., Sanford, J. C., Chen, J., Enns, C. A., & Wessling‐Resnick, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070199 · Cited by 60
“Mutations in HFE [25], transferrin receptor-2 [26], ferroportin [27], hepcidin [28], or hemojuvelin [29] have been identified in different forms of human disease.”
The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients
Buchanan, D. D., Silburn, P. A., Chalk, J. B., Couteur, D. G. L., & Mellick, G. D. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00398-1 · Cited by 61
The immunological system in hemochromatosis
de Sousa, M. A. B., & Porto, G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80367-x · Cited by 57
Neogenin Interacts with Hemojuvelin through Its Two Membrane-Proximal Fibronectin Type III Domains
Yang, F., West, A. P., Allendorph, G. P., Choe, S., & Bjorkman, P. J. (2008) · Biochemistry · doi:10.1021/bi800036h · Cited by 55
“other crucial iron-regulatory genes including HFE (encoding HFE) (3), TfR2 (encoding transferrin receptor 2) (4), SLC40A1 (encoding ferroportin) (5-8),HAMP (encoding hepcidin) (9-11), and HFE2 (encoding hemojuvelin or HJV) (12) have been discovered, and studies of their physiological roles have revealed additional asp…”
BackgroundGeier, A., Reugels, M. J., Weiskirchen, R., Wasmuth, H. E., Dietrich, C. G., Siewert, E., Gartung, C., Lorenzen, J., Bosserhoff, A., Brügmann, M., et al. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0928.x · Cited by 60
“Heterozygous C282Y status and homo- or heterozygosity for the H63D mutation do not usually induce a hemochromatosis phenotype (10, 11, 38), but the presence of these mutations may promote iron storage and could represent a clinically relevant comorbid factor in patients with chronic hepatitis C.”
BackgroundPathways for the regulation of body iron homeostasis in response to experimental iron overload
Theurl, I., Ludwiczek, S., Eller, K., Seifert, M., Artner, E., Brunner, P., & Weiß, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.030 · Cited by 63
“The membrane bound protein HFE which is mutated in approximately 80% of subjects with hereditary hemochromatosis [28], modulates the affinity of transferrin for TfR1 but its role in iron absorption remains elusive [29].”
BackgroundMcCullen, M., Crawford, D. H., & Hickman, P. E. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00711-2 · Cited by 57
Marx, J. J. M. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600440 · Cited by 57
Martinelli, A. L. C., Ramalho, L. N. Z., & Zucoloto, S. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03255.x · Cited by 64
Parham, P. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01378.x · Cited by 57
Molecular aspects of iron absorption: Insights into the role of HFE in hemochromatosis
Philpott, C. C. (2002) · Hepatology · doi:10.1053/jhep.2002.33466 · Cited by 65
Yersinia enterocolitica Infection with Multiple Liver Abscesses Uncovering a Primary Hemochromatosis
Höpfner, M., Nitsche, R., Rohr, A., Harms, D., Schubert, S., & Fölsch, U. R. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750066004 · Cited by 56
Genetic profiling of newborns: ethical and social issues
Almond, B. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1745 · Cited by 59
McLaren, C. E., McLachlan, S., Garner, C. P., Vulpe, C. D., Gordeuk, V. R., Eckfeldt, J. H., Adams, P. C., Acton, R. T., Murray, J. A., Leiendecker‐Foster, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038339 · Cited by 62
“Briefly, HFE C282Y and H63D genotypes were determined using the InvaderH Assay (Third Wave Technologies, Madison WI).”
BackgroundInfluentialTransgenic HFE‐dependent induction of hepcidin in mice does not require transferrin receptor‐2
Schmidt, P. J., & Fleming, M. D. (2012) · American Journal of Hematology · doi:10.1002/ajh.23173 · Cited by 55
“Here, although we are able to demonstrate by coimmunoprecipitation studies that a germline, transgenically expressed Hfe-cMyc chimeric protein is able to form a complex with either b2m or Tfr1, confirming earlier data [1,12,13], we were unable to confirm in vivo the Hfe–Tfr2 interaction reported in cell culture system…”
BackgroundResultTiwari, H. K., Barnholtz‐Sloan, J. S., Wineinger, N. E., Padilla, M. A., Vaughan, L. K., & Allison, D. B. (2008) · Human Heredity · doi:10.1159/000119107 · Cited by 65
Liver function: test selection and interpretation of results
Burke, M. D. (2002) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(01)00002-6 · Cited by 64
Pietrangelo, A. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111226 · Cited by 56
Multigenic control of hepatic iron loading in a murine model of hemochromatosis
Bensaid, M., Fruchon, S., Christine, M., Bahram, S., Roth, M., & Coppin, H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.021 · Cited by 57
Kaneko, Y., Miyajima, H., Piperno, A., Tomosugi, N., Hayashi, H., Morotomi, N., Tsuchida, K.-I., Ikeda, T., Ishikawa, A., Ota, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0259-8 · Cited by 55
“Hemochromatosis includes HFE-hemochromatosis mainly from the C282Y/C282Y mutation in HFE.1 Non-HFE hemochromatosis is associated with the hemojuvelin (HJV),2 human antimicrobial peptide (HAMP),3 and transferrin receptor 2 (TFR2)4 genes.”
BackgroundPerlmutter, D. L., de Azevedo, R. A., Kelly, D. A., Shepherd, R. W., & Tazawa, Y. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200208002-00016 · Cited by 56
“Parkhila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis.”
BackgroundInfluentialIron homeostasis and inherited iron overload disorders: an overview
Heeney, M. M., & Andrews, N. C. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.06.018 · Cited by 61
Iron Homeostasis and the Assessment of Iron Status
Sherwood, R. A., Pippard, M. J., & Peters, T. J. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500601 · Cited by 56
Recognition and management of hereditary hemochromatosis.
Brandhagen, D. J., Fairbanks, V. F., & Baldus, W. P. (2002) · PubMed · Cited by 64
Feder, J. N. (1999) · Immunologic Research · doi:10.1007/bf02786472 · Cited by 66
“It was theorized that this variant, which occurs in an extracellular portion of the molecule, might disrupt a ligand-receptor interaction of HFE ( 6 ).”
BackgroundInfluentialSelf-citationC282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
Frayling, T. M., Ellard, S., Grove, J. I., Walker, M., & Hattersley, A. T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78618-9 · Cited by 56
Mutation Analysis of the HFE Gene in Brazilian Populations
Agostinho, M. F., Arruda, V. R., Bassères, D. S. D. S., Bordin, S. A., Soares, M. C. P., de Menezes, R. C., Costa, F. F., & Saad, S. T. O. (1999) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1999.0260 · Cited by 62
“mutation was homozygous in 83% of North American hemochromatosis patients (1) and in more than 90% of UK, French and Australian hemochromatosis patients (3,4,5).”
BackgroundSun, H. S., Tsai, H., Ko, H., Chang, F., & Yeh, T. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00085.x · Cited by 54
“Feder et al. (1996) and Nielsen Genes, Brain and Behavior (2004) 3: 328–336 333 et al. (1999) suggested a strategy to search for disease susceptibility genes by testing for deviation from HWE among affected individuals.”
BackgroundAssociation of Mutations in the Hemochromatosis Gene With Shorter Life Expectancy
Bathum, L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.20.2441 · Cited by 56
Inherited Hfe–Unrelated Hemochromatosis in Italian Families
Camaschella, C., Fargion, S., Sampietro, M., Roetto, A., Bosio, S., Garozzo, G., Arosio, C., & Piperno, A. (1999) · Hepatology · doi:10.1002/hep.510290509 · Cited by 57
“All patients met the diagnostic phenotypic criteria for hemochromatosis by having at least two of the following: (1) increased fasting transferrin saturation (repeatedly greater than 50%) and raised serum ferritin, (2) histological iron of grade III to IV, (3) hepatic iron index equal to or greater than 2, and (4) tot…”
MethodHaplotype Fine Mapping by Evolutionary Trees
Lam, J. C., Roeder, K., & Devlin, B. (2000) · The American Journal of Human Genetics · doi:10.1086/302756 · Cited by 58
“Remarkably, the eight excluded haplotypes are precisely of the form of the eight supplementary haplotypes obtained from Feder et al. (1996), which do not carry the predominant HFE mutation.”
BackgroundMethodInfluentialClinical report of three patients with hereditary hemochromatosis and movement disorders
Demarquay, G., Setiey, A., Morel, Y., TREPO, C. G., Chazot, G., & Broussolle, E. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1204::aid-mds1021>3.0.co;2-t · Cited by 56
Delima, R. D., Chua, A. C. G., Tirnitz-Parker, J. E. E., Gan, E. K., Croft, K. D., Graham, R. M., Olynyk, J. K., & Trinder, D. (2012) · Hepatology · doi:10.1002/hep.25689 · Cited by 54
“mutation in the hemochromatosis protein (HFE).(3) Iron overload disease develops in up to 30% of these individuals and can result in significant hepatic, pancreatic, cardiac, or musculoskeletal tissue damage.”
BackgroundRamos, P., Guy, E., Chen, N., Proenca, C. C., Gardenghi, S., Casu, C., Follenzi, A., Van Rooijen, N., Grady, R. W., de Sousa, M., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307462 · Cited by 54
Lee, S. Y., Patton, S. M., Henderson, R. J., & Connor, J. R. (2006) · The FASEB Journal · doi:10.1096/fj.06-6397com · Cited by 60
“More than 80% of hemochromatosis patients are homozygous for the C282Y mutation (8, 11, 12).”
BackgroundThe influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo, F., Zecchina, G., Sbaiz, L., Fischer, R., Piga, A. G., & Camaschella, C. (1999) · PubMed · Cited by 66
Optimizing the diagnosis and the treatment of iron overload diseases
Brissot, P. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1119043 · Cited by 61
“The usual underlying genotype is homozygosity for the C282Y mutation [4] (new HFE terminology p.”
BackgroundEcogenetics of lead toxicity and its influence on risk assessment
Mani, M. S., Kabekkodu, S. P., Joshi, M. B., & Dsouza, H. S. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119851253 · Cited by 61
Screening for Hemochromatosis: Recommendation Statement
U.S. Preventive Services Task Force* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-3-200608010-00008 · Cited by 55
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis
Roetto, A., & Camaschella, C. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.004 · Cited by 58
Lohmueller, K. E., Mauney, M. M., Reich, D., & Braverman, J. M. (2005) · The American Journal of Human Genetics · doi:10.1086/499287 · Cited by 61
“…F5 DVT Arg506Gln Gln .044 (1,236) .00 (251) .044 .03 Rees et al. 1995; Hirschhorn et al. 2002 HFE HFE Cys382Tyr Tyr .038 (2,900) .00 (806) .038 .024 Feder et al. 1996; Merryweather-Clarke et al. 1997 MTHFR DVT C677T T .3 (188) .066 (468) .234 .205 Schneider et al. 1998; Ray et al. 2002 PPARG T2DM…”
Méndez, M., Sorkin, L., Rossetti, M. V., Astrin, K. H., Batlle, A. M. D. C., Parera, V. E., Aizencang, G. I., & Desnick, R. J. (1998) · The American Journal of Human Genetics · doi:10.1086/302119 · Cited by 55
“DNA was PCR amplified by the primers and conditions described by Feder et al. (1996).”
BackgroundMethodC282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients
Tannapfel, A., Stölzel, U., Köstler, E., Melz, S., Richter, M., Keim, V., Schuppan, D., & Wittekind, C. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100401 · Cited by 55
Transmission of Black Creek Canal virus between cotton rats
Hutchinson, K. L., Rollin, P. E., Shieh, W., Zaki, S. R., Greer, P. W., & Peters, C. J. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200001)60:1<77::aid-jmv13>3.0.co;2-s · Cited by 43
Press, R. D. (1999) · Archives of Pathology & Laboratory Medicine · doi:10.5858/1999-123-1053-hh · Cited by 58
Singh, A. V., Subhashree, L., Milani, P., Gemmati, D., & Zamboni, P. (2010) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734610384653 · Cited by 65
“3), and is considered an autosomal recessive iron-overload disorder called classic hereditary hemochromatosis.(79) The prevalence of this gene variant is 10 times higher than cystic fibrosis and the homozygosity is found in approximately 5 of every 1000 persons of Northern European descent.”
BackgroundWright, R. O., Silverman, E. K., Schwartz, J. D., Tsaih, S.-W., Senter, J., Sparrow, D., Weiss, S. T., Aro, A., & Hu, H. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6581 · Cited by 58
Iron absorption in male C282Y heterozygotes
Roe, M. A., Heath, A. M., Oyston, S. L., Macrow, C., Hoogewerff, J. A., Foxall, R., Dainty, J. R., Majsak‐Newman, G., Willis, G. A., & Fairweather‐Tait, S. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.4.814 · Cited by 59
Iron Metabolism and the Inflammatory Response
Martins, A. C., Almeida, J. I., Lima, I. S., Kapitão, A., & Gozzelino, R. (2017) · IUBMB Life · doi:10.1002/iub.1635 · Cited by 59
“To note that HFE encodes major histocompatibility complex-class I-like protein, which is mutated in approximately 85% of patients with HH (84).”
BackgroundKennedy, M. W., Heikema, A. P., Cooper, A., Björkman, P. J., & Sanchez, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100301200 · Cited by 54
Liver Biopsy: Evolving Role in the New Millennium
Sheela, H., Seela, S., Caldwell, C. A., Boyer, J. L., & Jain, D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000170742.59134.60 · Cited by 61
“Feder et al in 1996 linked the HLA locus to the short arm of chromosome 6, which was subsequently determined to be the HFE gene.(27,28) Two major mutations involving HFE gene are commonly referred to as C282Y and H63D.”
Elevated hepatic iron: A confounding factor in chronic hepatitis C
Isom, H. C., McDevitt, E. I., & Moon, M. S. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.009 · Cited by 56
Jin, F., Qu, L., & Shen, X. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-18 · Cited by 61
“A second missense mutation in the HFE gene, H63D, is found in about 4% of patients with HH, but its role in iron overload is still debated [6].”
BackgroundGiannetti, A. M., Halbrooks, P. J., Mason, A. B., Vogt, T. M., Enns, C. A., & Björkman, P. J. (2005) · Structure · doi:10.1016/j.str.2005.07.016 · Cited by 58
“The crystal structure of the soluble ectodomain of TfR has been reported alone (Lawrence et al., 1999) and in complex with HFE (Bennett et al., 2000), the protein mutated in patients with the iron overload disorder hereditary hemochromatosis (Feder et al., 1996).”
BackgroundA Reverse-Hybridization Assay for the Rapid and Simultaneous Detection of Nine HFE Gene Mutations
Oberkanins, C., Moritz, A., de Villiers, J. N. P., Kotze, M. J., & Kury, F. (2000) · Genetic Testing · doi:10.1089/10906570050114812 · Cited by 54
Primary Liver Carcinoma in Genetic Hemochromatosis Reveals a Broad Histologic Spectrum
Morcos, M., Dubois, S., Bralet, M., Belghiti, J., Degott, C., & Terris, B. (2001) · American Journal of Clinical Pathology · doi:10.1309/2rfk-hd06-a788-1fjh · Cited by 54
“In nontumoral tissue, we classified the following: (1) the degree of fibrosis according to the METAVIR classification (scores ranging from 0 to 4)15; (2) a histologic hepatic iron index (HHII) determined by the ratio of total histologic iron score (sum of hepatocytic, sinusoidal, and portal iron scores ranging from 0…”
MethodRhodes, D. A., Raha-Chowdhury, R., Cox, T. M., & Trowsdale, J. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.9.761 · Cited by 54
Hemochromatosis: Association of Severity of Iron Overload with Genetic Markers
Barton, J. C., Harmon, L., Rivers, C. A., & Acton, R. T. (1996) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1996.0100 · Cited by 54
“Recently, a gene with structural similarities to the MHC class I family has been identified which contains two missense alterations, one of which was homozygous in 83% of hemochromatosis patients ( 34 ).”
BackgroundScreening for Hemochromatosis in Primary Care Settings
McDonnell, S. M., Phatak, P. D., Felitti, V., Hover, A., & McLaren, G. D. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00007 · Cited by 54
“These lower cut-points have not been directly tested for their association with the newly described genetic HFE mutations or clinical outcomes (27-29).”
Background[Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].
Toxqui, L., Piero, A. D., Courtois, V., Bastida, S., Sánchez-Muniz, F. J., & Vaquero, M. P. (2011) · PubMed · doi:10.3305/nh.2010.25.3.4583 · Cited by 50
Nielsen, P., Engelhardt, R., Düllmann, J., & Fischer, R. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0583 · Cited by 55
Iron Imports. VI. HFE and regulation of intestinal iron absorption
Fleming, R. E., & Britton, R. S. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00486.2005 · Cited by 54
“HFE is a 343-amino acid cell surface protein with homology to major histocompatibility complex (MHC) class I molecules (12).”
BackgroundPalka, P., Macdonald, G. A., Lange, A., & Burstow, D. J. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.118032 · Cited by 53
Stickel, F., Buch, S., Zoller, H., Hultcrantz, R., Gallati, S., Osterreicher, C., Finkenstedt, A., Stadlmayr, A., Aigner, E., Sahinbegovic, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu076 · Cited by 52
“The majority of HH cases are due to a variation in HFE gene located on chromosome 6 (8), and .”
BackgroundCrosstalk between Iron Metabolism and Erythropoiesis
Li, H., & Ginzburg, Y. Z. (2010) · Advances in Hematology · doi:10.1155/2010/605435 · Cited by 59
“Homozygous C282Y mutation, which accounts for more than 80% HH patients [73], disturbs formation of a disulfide bond in the α3 domain of HFE, prevents its binging to β2-microglobulin— a protein involved in the regulation of iron absorption, and markedly reduces the appearance of HFE on the cell surface.”
BackgroundHepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi, T., Hasuike, Y., Otaki, Y., Kida, A., Nonoguchi, H., & Kuragano, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr410 · Cited by 58
“The prevalence of carotid plaque was significantly higher in patients with hyperferritinemia and normal HFE than in all the other groups.”
BackgroundInfluentialPrevalence of iron deficiency in 62,685 women of seven race/ethnicity groups: The HEIRS Study
Barton, J. C., Wiener, H. H., Acton, R. T., Adams, P. C., Eckfeldt, J. H., Gordeuk, V. R., Harris, E. L., McLaren, C. E., Harrison, H., McLaren, G. D., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232125 · Cited by 48
“The hemochromatosis gene HFE ("high-iron") is linked to the major histocompatibility complex on chromosome 6p [11].”
BackgroundHemochromatosis subjects as allogeneic blood donors: a prospective study
Leitman, S. F., Browning, J. N., Yau, Y. Y., Mason, G., Klein, H. G., Conry‐Cantilena, C., & Bolan, C. D. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00570.x · Cited by 55
Gleeson, F., Ryan, E., Barrett, S., & Crowe, J. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200409000-00008 · Cited by 51
Gemmati, D., Zeri, G., Orioli, E., Gaetano, F. E. D., Salvi, F., Bartolomei, I., D’Alfonso, S., Dall’Osso, C., Leone, M. A., Singh, A. V., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-70 · Cited by 58
“C282Y and H63D are the two commonest diseaseassociated variants in the HFE gene, and iron-dependent inflammation seems to be influenced by both polymorphisms [12-15].”
BackgroundModulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes
Bartolomei, G., Çevik, R. E., & Marcello, A. (2011) · Journal of General Virology · doi:10.1099/vir.0.032706-0 · Cited by 58
“The classical hereditary haemochromatosis (HH), an autosomal recessive disorder, is most often caused by mutations in a gene encoding a MHC class I-like protein with unknown function (HFE) (Feder et al., 1996).”
BackgroundInfluentialHulgan, T., Tebas, P., Canter, J. A., Mulligan, K. M., Haas, D. W., Dubé, M. P., Grinspoon, S. K., Robbins, G. K., Motsinger‐Reif, A. A., & Kallianpur, A. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/528697 · Cited by 53
“Although these common HFE gene variants have been shown to impact iron transport, their individual effects may differ qualitatively and by cell type [14, 27–29].”
BackgroundInfluentialMolecular insights into the pathogenesis of hereditary haemochromatosis
Pietrangelo, A. (2006) · Gut · doi:10.1136/gut.2005.078063 · Cited by 54
Griffiths, W. J., & Cox, T. M. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100507 · Cited by 58
“1994), provides corroborative evidence that the C282Y variant of HFE is responsible for human iron storage disease (Feder et al. 1996).”
BackgroundIron overload in urban Africans in the 1990s
Gangaidzo, I. T., Moyo, V. M., Saungweme, T., Khumalo, H., Charakupa, R. M., Gomo, Z. A. R., Loyevsky, M., Stearman, R., Vaute, T. L., Enquist, E. G., et al. (1999) · Gut · doi:10.1136/gut.45.2.278 · Cited by 53
Merryweather‐Clarke, A. T., Siimonsen, H., Shearman, J. R., Pointon, J. J., N�rgaard-Pedersen, B., & Robson, K. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:2<154::aid-humu8>3.0.co;2-e · Cited by 56
Genetic haemochromatosis: genes and mutations associated with iron loading
Camaschella, C. (2002) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(02)90207-0 · Cited by 52
Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
Dostalikova‐Cimburova, M., Balušíková, K., Krátká, K., Chmelíková, J., Hejda, V., Hnaníček, J., Neubauerová, J., Vránová, J., Kovár̆, J., & Horák, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12310 · Cited by 55
“HFE, responsible for hereditary haemochromatosis, is another regulatory protein associated with iron metabolism [25].”
BackgroundRishi, G., Crampton, E. M., Wallace, D. F., & Subramaniam, V. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077267 · Cited by 49
“Mutations in HFE and transferrin receptor 2 (TFR2) cause hereditary hemochromatosis [1,2], which is characterized by an inappropriate hepcidin (HAMP) expression relative to body iron levels [3].”
BackgroundFactors influencing disease phenotype and penetrance in HFE haemochromatosis
Rochette, J., Gac, G. L., Lassoued, K., Férec, C., & Robson, K. (2010) · Human Genetics · doi:10.1007/s00439-010-0852-1 · Cited by 58
“…with hereditary haemochromatosis are homozygous for the same mutation in the HFE gene, resulting in the substitution of Cys to Tyr at residue 282 (p.C282Y mutation) of the HFE protein (Feder et al. 1996; Jazwinska et al. 1996; Jouanolle et al. 1996; Carella et al. 1997; Worwood et al. 1997).”
BackgroundYun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 63
“HFE is a major histocompatibility omplex class I (MHC I) like protein lacking antigen presentng capability [72,78].”
BackgroundInfluentialDiagnostic histochemistry in hepatic pathology
Iezzoni, J. C. (2018) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2018.10.003 · Cited by 52
The Role of Iron in Alcohol-Mediated Hepatocarcinogenesis
Mueller, S., & Rausch, V. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_6 · Cited by 54
Stuart, K. A., Fletcher, L. M., Clouston, A. D., Lynch, S. V., Purdie, D. M., Kerlin, P., & Crawford, D. H. (2000) · Hepatology · doi:10.1053/jhep.2000.20348 · Cited by 56
Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases
Nielsen, P., Fischer, R., Buggisch, P., & Janka-Schaub, G. E. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04708.x · Cited by 52
A survey of phlebotomy among persons with hemochromatosis
McDonnell, S. M., Grindon, A. J., Preston, B. L., Barton, J. C., Edwards, C. Q., & Adams, P. C. (1999) · Transfusion · doi:10.1046/j.1537-2995.1999.39060651.x · Cited by 52
Lee, P. L., Barton, J. C., Brandhagen, D. J., & Beutler, E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05165.x · Cited by 52
Hemochromatosis Due to Mutations in Transferrin Receptor 2
Roetto, A., Daraio, F., Alberti, F., Porporato, P. E., Calì, A., Gobbi, M. D., & Camaschella, C. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0585 · Cited by 56
HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia
Parkkila, S., Niemelä, O. J., Savolainen, E., & Koistinen, P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41060828.x · Cited by 58
Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload
Zaahl, M. G., Merryweather‐Clarke, A. T., Kotze, M. J., der Merwe, V., Warnich, L., & Robson, K. (2004) · Human Genetics · doi:10.1007/s00439-004-1166-y · Cited by 56
Metadata
- Authors
- Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prass, C. E., Quintana, L., Starnes, S. M., Schatzman, R. C., Brunke, K. J., Drayna, D. T., Risch, N. J., Bacon, B. R., & Wolff, R. K.
- Affiliations
- Stanford Medicine (US)
- Saint Louis University (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1996-08
- Volume
- 13
- Issue
- 4
- Pages
- 399-408
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2002605005
- Cited by
- 3,664
- References
- 78
- Citations by year
- 2026: 27 · 2025: 27 · 2024: 38 · 2023: 47 · 2022: 51 · 2021: 47 · 2020: 67 · 2019: 50 · 2018: 58 · 2017: 92 · 2016: 87 · 2015: 80 · 2014: 74 · 2013: 94 · 2012: 96
- FWCI
- 124.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HLA-H, HLA-F, missense mutations, iron metabolism, iron accumulation, linkage disequilibrium, haplotype analysis, homozygosity, gene inactivation
- MeSH terms
- Hemochromatosis Protein, Alleles, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 6, Cloning, Molecular, Cysteine, Biological Evolution, Genes, MHC Class I, Genetic Markers, Haplotypes, Hemochromatosis, HLA Antigens, Humans, Major Histocompatibility Complex, Membrane Proteins, Molecular Sequence Data, RNA, Messenger, Histocompatibility Antigens Class I, Linkage Disequilibrium, Gene Expression, Sequence Alignment, Sequence Homology, Amino Acid, DNA Primers, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.